Adenosine and Thalidomide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Adenosine (adenosine) and Thalidomide (thalidomide). Common drug interactions include plasma cell myeloma among males.

The phase IV clinical study analyzes what interactions people have when they take Adenosine and Thalidomide. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Adenosine?

Adenosine has active ingredients of adenosine. eHealthMe is studying from 2,711 Adenosine users. Check the latest studies of Adenosine.

What is Thalidomide?

Thalidomide has active ingredients of thalidomide. eHealthMe is studying from 16,473 Thalidomide users. Check the latest studies of Thalidomide.



On Jul, 14, 2026

11 people who take Adenosine and Thalidomide together, and have interactions are studied.

Adenosine and Thalidomide drug interactions.

What are the common drug interactions of Adenosine and Thalidomide, by gender? *:

female:

n/a

male:

  1. Plasma cell myeloma (cancer that begins in plasma cells)
  2. Pleural effusion (water on the lungs)
  3. Pneumonia
  4. Cholecystitis acute (rapid infection of gallbladder)
  5. Rash pustular (redness with pustules)
  6. Nausea (feeling of having an urge to vomit)
  7. Vomiting
  8. Decreased appetite

What are the common drug interactions of Adenosine and Thalidomide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Plasma cell myeloma (cancer that begins in plasma cells)
  2. Pleural effusion (water on the lungs)
  3. Pneumonia
  4. Cholecystitis acute (rapid infection of gallbladder)
  5. Rash pustular (redness with pustules)
  6. Nausea (feeling of having an urge to vomit)
  7. Vomiting
  8. Decreased appetite

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 11 people, 100.00%
  2. Liver Disorder (liver diseases): 6 people, 54.55%
  3. Sleep Disorder: 4 people, 36.36%
  4. Hypolipidaemia (an abnormally high concentration of fats or lipids in the blood): 4 people, 36.36%
  5. Gastrointestinal Bacterial Infection (infection of the stomach and intestines caused by bacteria): 4 people, 36.36%

* Approximation only. Some reports may have incomplete information.

Do you take Adenosine and Thalidomide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Adenosine and Thalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Adenosine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Thalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Adenosine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Thalidomide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on adenosine and thalidomide (the active ingredients of Adenosine and Thalidomide, respectively), and Adenosine and Thalidomide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: